PopulationsHumans
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI): Ten Years of Progress in Understanding Alzheimer's in Down Syndrome
AAIC 2025 Abstract
Abstract
Background: Down syndrome (DS) is a form of genetically determined Alzheimer's disease (AD). Understanding the natural history and biomarker specificities in this population can offer insights into AD pathogenesis and potential treatment targets.
The paper
Laura Videla, Bessy Benejam, Isabel Barroeta, Juan Fortea
Show 19 more authors
Susana Fernández, Javier Arranz, Íñigo Rodríguez‐Baz, José Enrique Arriola‐Infante, Lucía Maure‐Blesa, Laura Del Hoyo, Lídia Vaqué‐Alcázar, Mateus Rozalem Aranha, Alejandra Omaira Morcillo-Nieto, Sara Erzsebet Zsadanyi, Valle Camacho, Sandra Giménez, Olivia Belbin, Daniel Andres Alcolea, Alexandre Bejanin, Sebastián Videla, Rafael Blesa, Alberto Lleó, María Carmona‐Iragui,Universitat Autònoma de Barcelona
AAIC 2025 Abstract · 10 Jan 2026 · CC BY
Presented at AAIC 2025
